The document discusses key aspects of developing a global regulatory strategy for drug development and registration. It outlines the long development timeline and costs to bring a drug to market. It also describes the regulatory approval processes in the US, EU and Japan, including application formats, timelines and opportunities to expedite review of important new drugs. Developing an integrated global strategy from early research can help optimize the development plan and registration across regions.